Barriers for conducting clinical trials in developing countries- a systematic review
Abstract Background Clinical trials for identification of efficient and effective new diagnostic and treatment modalities are needed to address disproportionately high burden of communicable (e.g., HIV/AIDS, tuberculosis, and malaria) and non-communicable diseases (e.g., diabetes) in developing coun...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-03-01
|
Series: | International Journal for Equity in Health |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12939-018-0748-6 |
id |
doaj-0a41dcc3afca4bbd9f83b73f5f738285 |
---|---|
record_format |
Article |
spelling |
doaj-0a41dcc3afca4bbd9f83b73f5f7382852020-11-24T21:23:14ZengBMCInternational Journal for Equity in Health1475-92762018-03-0117111110.1186/s12939-018-0748-6Barriers for conducting clinical trials in developing countries- a systematic reviewChalachew Alemayehu0Geoffrey Mitchell1Jane Nikles2Faculty of Medicine University of QueenslandFaculty of Medicine University of QueenslandThe University of Queensland Centre for Clinical Reseaerch (UQCCR)Abstract Background Clinical trials for identification of efficient and effective new diagnostic and treatment modalities are needed to address disproportionately high burden of communicable (e.g., HIV/AIDS, tuberculosis, and malaria) and non-communicable diseases (e.g., diabetes) in developing countries. However, gross under-representation in global clinical trial platforms contributes to sustained health inequity in these countries. We reviewed the literature on barriers facing clinical researchers in developing countries for conducting clinical trials in their countries. Methods Literature indexed in PubMed, Embase, CINAHL and Web of Science, WHO Global Health Library were searched. Grey literature was also searched. Search key words included barriers, challenges, clinical trials and developing countries. Articles within the scope of this review were appraised by two reviewers. Results Ten studies, which are reported in 15 papers, were included in this review. Following critical review we identified five unifying themes for barriers. Barriers for conducting clinical trials included lack of financial and human capacity, ethical and regulatory system obstacles, lack of research environment, operational barriers and competing demands. Conclusion and recommendation There were substantial barriers at system, organization and individual level. We propose that to address this problem, instituting a system for wider implementation of local investigator-initiated trials is warranted. These trials are more applicable to local populations because they build on local healthcare knowledge. They are more demand-led, influence policy and responsive to a country’s needs because they are driven by a local or national agenda.http://link.springer.com/article/10.1186/s12939-018-0748-6BarriersClinical trialsDeveloping countries |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Chalachew Alemayehu Geoffrey Mitchell Jane Nikles |
spellingShingle |
Chalachew Alemayehu Geoffrey Mitchell Jane Nikles Barriers for conducting clinical trials in developing countries- a systematic review International Journal for Equity in Health Barriers Clinical trials Developing countries |
author_facet |
Chalachew Alemayehu Geoffrey Mitchell Jane Nikles |
author_sort |
Chalachew Alemayehu |
title |
Barriers for conducting clinical trials in developing countries- a systematic review |
title_short |
Barriers for conducting clinical trials in developing countries- a systematic review |
title_full |
Barriers for conducting clinical trials in developing countries- a systematic review |
title_fullStr |
Barriers for conducting clinical trials in developing countries- a systematic review |
title_full_unstemmed |
Barriers for conducting clinical trials in developing countries- a systematic review |
title_sort |
barriers for conducting clinical trials in developing countries- a systematic review |
publisher |
BMC |
series |
International Journal for Equity in Health |
issn |
1475-9276 |
publishDate |
2018-03-01 |
description |
Abstract Background Clinical trials for identification of efficient and effective new diagnostic and treatment modalities are needed to address disproportionately high burden of communicable (e.g., HIV/AIDS, tuberculosis, and malaria) and non-communicable diseases (e.g., diabetes) in developing countries. However, gross under-representation in global clinical trial platforms contributes to sustained health inequity in these countries. We reviewed the literature on barriers facing clinical researchers in developing countries for conducting clinical trials in their countries. Methods Literature indexed in PubMed, Embase, CINAHL and Web of Science, WHO Global Health Library were searched. Grey literature was also searched. Search key words included barriers, challenges, clinical trials and developing countries. Articles within the scope of this review were appraised by two reviewers. Results Ten studies, which are reported in 15 papers, were included in this review. Following critical review we identified five unifying themes for barriers. Barriers for conducting clinical trials included lack of financial and human capacity, ethical and regulatory system obstacles, lack of research environment, operational barriers and competing demands. Conclusion and recommendation There were substantial barriers at system, organization and individual level. We propose that to address this problem, instituting a system for wider implementation of local investigator-initiated trials is warranted. These trials are more applicable to local populations because they build on local healthcare knowledge. They are more demand-led, influence policy and responsive to a country’s needs because they are driven by a local or national agenda. |
topic |
Barriers Clinical trials Developing countries |
url |
http://link.springer.com/article/10.1186/s12939-018-0748-6 |
work_keys_str_mv |
AT chalachewalemayehu barriersforconductingclinicaltrialsindevelopingcountriesasystematicreview AT geoffreymitchell barriersforconductingclinicaltrialsindevelopingcountriesasystematicreview AT janenikles barriersforconductingclinicaltrialsindevelopingcountriesasystematicreview |
_version_ |
1725992803280879616 |